Use of Polysaccharide for Treating ST-Elevation Myocardial Infarction and Diseases of the Digestion System
AssigneePT. Sahabat Lingkungan Hidup
InventorsPeter Sugita, Wiwiek Widyastuti Budiliantono, Aurelia Maxine Sugita
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of treating ST-elevation myocardial infarction (STEMI) and diseases of the digestion system using β-1,3/1,6-D-glucan derived from mycellium extract of Ganoderma lucidum. Methods of treating ST-elevation myocardial infarction (STEMI) and diseases of the digestion system using a polysaccharide comprising β-1,3/1,6-D-glucan are also provided.
Claims12
1-37. (canceled)
A method of treating ST-elevation myocardial infarction in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of β-1,3/1,6-D-glucan, or a pharmaceutically acceptable salt thereof, wherein the β-1,3/1,6-D-glucan, or a pharmaceutically acceptable salt thereof, has been substantially isolated from Ganoderma lucidum mycelium.
A method of treating ST-elevation myocardial infarction in a subject in need thereof, comprising administering to the subject a therapeutically amount of a pharmaceutical composition comprising β-1,3/1,6-D-glucan, or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients, wherein the β-1,3/1,6-D-glucan, or a pharmaceutically acceptable salt thereof, has been substantially isolated from Ganoderma lucidum mycelium.
Dependencies are inferred from the claim text.